.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Recent clinical findings highlight the potential of vaginal PRP injection as a therapeutic option for enhancing sexual health in women. Furthermore, a pilot randomized controlled trial (RCT) recently published in Obstetrics & Gynecology evaluated 52 premenopausal women. Specifically, researchers compared a one-time anterior vaginal wall injection of platelet-rich plasma (PRP) to a saline placebo.
Consequently, the study found that women treated with PRP experienced a significantly greater increase in their total Female Sexual Function Index (FSFI) scores. Moreover, at the six-week mark, the PRP group showed a median score change of 2.2 compared to only 0.3 in the control group. This improvement remained visible at the six-month follow-up. However, while subscale scores for desire, arousal, and lubrication improved, these specific changes did not reach statistical significance against the control. Additionally, nearly 70% of the PRP group reported overall improvement on the Patient Global Impression of Improvement (PGI-I) scale. Therefore, this suggests that the procedure is not only effective but also yields high patient satisfaction. Finally, clinicians reported no serious adverse events, confirming a favorable safety profile.
Platelet-rich plasma contains concentrated growth factors that stimulate tissue regeneration, improve blood flow, and enhance nerve sensitivity in the vaginal wall.
Yes, the latest clinical data indicates that the procedure is well-tolerated. In the randomized trial, participants reported no serious adverse events over a six-month period.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
1. Clarke B et al. Vaginal Injection of Platelet-Rich Plasma for Sexual Function: A Randomized Controlled Trial. Obstet Gynecol. 2026 Mar 19. doi: 10.1097/AOG.0000000000006256. PMID: 41855531.
2. De Ponte A et al. Platelet-rich plasma in the management of vulvovaginal disorders: a systematic review. J Sex Med. 2026 Jan 5;23(1):qdaf307. doi: 10.1093/jsxmed/qdaf307. PMID: 41168677.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A recent RCT demonstrates that vaginal PRP injections significantly improve sexual function scores and patient satisfaction in premenopausal women....
5 months ago
A large NHANES cohort study reveals that higher Healthy Eating Index scores significantly reduce all-cause mortality risk in CKD patients by 45%. This analysis highlights the importance of comprehensive diet quality and medical nutrition therapy in renal care to optimize long-term clinical survival.
Today
A prospective cohort study demonstrates that poor adolescent sleep quality, especially long sleep latency and reduced efficiency, increases dysmenorrhea severity in young adulthood. Addressing adolescent rest patterns offers a critical preventive avenue for clinicians.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Today
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
